Support breast cancer research with your purchase!

Pink Ribbon Hand Relief. Photo:

It’s that time of year again: Breast Cancer Awareness month! This year marks twenty-five years of celebrating those who have triumphed over breast cancer, educating and empowering women to help protect themselves with early detection and advocating for a cure. There are many ways you can contribute to the cause: saving Yoplait yogurt lids, walking in the Susan G. Komen 3-Day for the Cure or by buying Aveda’s Pink Ribbon Hand Relief™.

For every bottle of Pink Ribbon Hand Relief™ sold, Aveda will donate $4 to The Breast Cancer Research Foundation, whose mission is to “achieve prevention and a cure for breast cancer in our lifetime by providing critical funding for innovative clinical and translational research at leading medical centers worldwide, and increasing public awareness about good breast health…” This foundation is the only cancer organization to hold an A+ from the American Institute of Philanthropy, according to their official website.

Why should you donate? Because about 1 in 8 women in the United States will develop invasive breast cancer over the course of her lifetime ( This could be your mother, sister, neighbor, teacher, girlfriend, niece… or you. Supporting research and awareness with your purchase will save lives.

What’s in it for you? Aveda Hand Relief™ is one of the best-selling items in the entire Aveda line and the Pink Ribbon Hand Relief™ is 20% larger than regular sizes, so you're saving money! The lotion soothes dry, chapped hands and instantly improves its condition. Plant emollients, humectants and anti-oxidants also help diminish the signs of aging; according to Ellen Marmur, MD, chief dermatological and cosmetic surgery at Mount Sinai Medical Center, "Hands not only are susceptible to the first signs of aging, but very often age even faster than the face.” (WedMD). So, show your paws some of the love you show your crow’s feet, while donating at the same time!

Because together, we can find a cure.

comments powered by Disqus